Abstract
The use of potentially inappropriate medications (PIMs) represents a priority issue in the care of older adults. This age group experiences physiological changes that alter the pharmacokinetics and pharmacodynamics of medications, increasing the risk of adverse effects, interactions, and avoidable hospitalizations. This study aims to determine the prevalence of use of potentially inappropriate medications, specifically benzodiazepines (BZDs), nonsteroidal anti-inflammatory drugs (NSAIDs), and proton pump inhibitors (PPIs), in older adult patients receiving home care in the City of Buenos Aires. An observational, descriptive, and cross-sectional study was conducted on a sample of 51 patients from the Home Care Service in Buenos Aires City. Mean age was 84.2 years (range 70–108). Polypharmacy (≥5 drugs) was present in 67.3 % of patients and extreme polypharmacy (≥10 drugs) in 16%. At least one potentially inappropriate medication was used by 69.1% of patients, mainly benzodiazepines (55%) and proton pump inhibitors (35%), with nonsteroidal anti-inflammatory drugs accounting for 24%. The findings reinforce the need to optimize prescribing and promote rational deprescribing strategies in the home setting.
References
1. Instituto Nacional de Estadística y Censos (INDEC). Proyecciones y estimaciones de población 2022. Buenos Aires: INDEC; 2023.
2. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.
3. Fried TR, O’Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261–72.
4. Morin L, Johnell K, Laroche ML, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289–98.
5. Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–96.
6. López-Torres Hidalgo J, Márquez-Calderón S. Polypharmacy and frailty in older adults: a critical review. Eur Geriatr Med. 2020;11(4):527–40.
7. American Geriatrics Society 2023 Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2023;71(4):923–49.
8. Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.
9. Reeve E, Gnjidic D, Long J, Hilmer SN. A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.
10. Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. Drugs Aging. 2007;24(1):21–31.
11. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–84.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
13. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.
14. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1983;17(1):37–49.
15. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J. 1965;14:61–5.
16. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.
17. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–94.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Washington, DC: APA; 2013.
19. Turner G, Clegg A; British Geriatrics Society; Age UK; Royal College of General Practitioners. Best practice guidelines for the management of frailty. Age Ageing. 2014;43(6):744–7.
20. Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug–drug interactions: population database analysis 1995–2010. BMC Med. 2015; 13:74.
21. Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Marien S, et al. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71(12):1415–27.
22. Pérez T, Moriarty F, Wallace E, McDowell R, Redmond P, Fahey T. Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: a longitudinal study. BMJ. 2018;363:k4524.
23. Gutiérrez-Valencia M, Izquierdo M, Malafarina V, Alonso-Renedo J, García-González AI, Sáez-López P, et al. Impact of polypharmacy on functional capacity in older adults: a prospective cohort study. J Am Med Dir Assoc. 2018;19(1):70–5.
24. Blanco-Reina E, García-Merino MR, Ocaña-Riola R, Ariza-Zafra G, Valdizán-Palacios E, Bellido-Esteban P. Potentially inappropriate medication in older people: advances in Beers Criteria. Int J Clin Pharm. 2024;46(1):12–22.
This work is licensed under a Creative Commons Attribution 4.0 International License.